Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
Palo Alto (17 mi)Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Phase 1
Waitlist Available
Sponsor: MBX Biosciences
Trial Summary
What is the purpose of this trial?This trial tests a new drug called MBX 2109, given as an injection under the skin, in healthy volunteers. The study aims to see how the drug is processed by the body, its effects, and if it is safe.
Eligibility Criteria
Treatment Details
3Treatment groups
Experimental Treatment
Placebo Group
Group I: MBX 2109 (Part B)Experimental Treatment1 Intervention
Repeated ascending SC doses
Group II: MBX 2109 (Part A)Experimental Treatment1 Intervention
Single ascending SC doses
Group III: PlaceboPlacebo Group1 Intervention
Find a clinic near you
Research locations nearbySelect from list below to view details:
Labcorp Drug Development: Clinical Research UnitDallas, TX
Labcorp Drug Development: Clinical Research UnitMadison, WI
Loading ...
Who is running the clinical trial?
MBX BiosciencesLead Sponsor